Cited by 5

The DOI matches its Crossref record.

Author Correction: Single-cell transcriptomics identifies Mcl-1 as a target for senolytic therapy in cancer

Troiani, Martina, Colucci, Manuel, D’Ambrosio, Mariantonietta, Guccini, Ilaria, Pasquini, Emiliano, Varesi, Angelica, Valdata, Aurora, Mosole, Simone, Revandkar, Ajinkya, Attanasio, Giuseppe, Rinaldi, Andrea, Rinaldi, Anna, Bolis, Marco, Cippà, Pietro, Alimonti, Andrea·2023·Nature Communications

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-023-40080-9

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • First-generation senolytics face resistance mechanisms such as MCL-1 upregulation.

    “resistance mechanisms such as MCL-1 upregulation, and negative outcomes in some models21”

    From Emerging strategies in senotherapeutics: from broad-spectrum senolysis to precision reprogramming (2026) · cites this paper as [55]

    The Author Correction (page not specified) describes image and figure-legend errors, including one involving an ABT263 image. It does not address MCL-1 upregulation as a resistance mechanism or negative outcomes in models; searches for those points returned only the correction text. (LLM, conf=0.76)

    Experimental — accuracy not yet measured
  • Senescent cells can evade elimination by upregulating alternative survival pathways such as MCL-1 or modulating immune checkpoints.

    “the capacity of SnCs to evade elimination by upregulating alternative survival pathways (such as MCL-1)54,55 or modulating immune checkpoints underscore the need for more sophisticated therapeutic approaches56.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

Sorted by citations

Metadata

Authors
Troiani, M., Colucci, M., D’Ambrosio, M., Guccini, I., Pasquini, E., Varesi, A., Valdata, A., Mosole, S., Revandkar, A., Attanasio, G., Rinaldi, A., Rinaldi, A., Bolis, M., Cippà, P., & Alimonti, A.
Venue
Nature Communications
Published
2023-07-20
Volume
14
Issue
1
ISSN
2041-1723
Cited by
5
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review